The purpose of this paper is to present in details, an extended case-study focused on emerging in vitro Diagnostics Technology as reflected on retrieved and evaluated Industrial Property Documents. More specific, this study comprises of the state-of-the-art and the perspectives of automatic Immunoassay Analyzers, it follows the innovation patent-trail from Flow Cytometry to Quantum Dots applications in the in vitro Diagnostics of tomorrow and finally, it provides an overview of the trends in Next Generation Nucleic Acid and Protein Sequencing, all of them as depicted on numerous relevant, retrieved and processed Industrial Property Documents.